Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Active Rheumatoid Arthritis

Interventions

DRUG

CDP870

Self-injection

Trial Locations (15)

Aichi

Fukuoka

Gunma

Hiroshima

Hokkaido

Hyōgo

Kagawa

Kagoshima

Kanagawa

Kumamoto

Nagasaki

Ōita

Saitama

Tokushima

Tokyo